×

What are you searching for?




Business

4 Min read

KOMIPHARM YET TO GET APPROVAL TO TEST PANAPHIX DRUG – COVID-19

Published On 05 Mar 2020 11:49 AM


SHARE THIS ARTICLE  


Highlights

  • Market observers wait for Komipharm drug test approvals, hoping to invest in company shares
  • Korea Exchange has warned against unchecked fluctuations in coronavirus-themed stocks
  • The company experienced an upward streak in their stocks for five consecutive days

According to a report by The Korea Herald, Komipharm is confident about the upcoming develop....


Tags : KOMIPHARM, KOSDAQ, STOCK MARKET, STOCK PRICE RISE, DRUG APPROVAL, PANAPHIX,
SHARE THIS ARTICLE  

Leave a comment 

comments (0)